Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials

Matt A. Brown, Ram J. Bishnoi, Sara Dholakia, Dawn I. Velligan

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences